Intrinsic value of Invex Therapeutics Ltd (IXC)
Live fair value data for Invex Therapeutics Ltd (IXC) is currently unavailable. Please check again shortly.
Current Price: $328.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Invex Therapeutics Ltd (IXC) undervalued or overvalued?
Based on the current model output, Invex Therapeutics Ltd appears to be undervalued with a upside of 61.00%.
Fair value vs market price — Invex Therapeutics Ltd (IXC)
Unlock premium access to view the live fair value comparison against current market price for IXC.
Frequently Asked Questions - IXC
How is IXC intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for IXC.
Is IXC undervalued or overvalued right now?
IXC is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for IXC: open their intrinsic value pages.